I have very rich content now. Let me compile the comprehensive answer from Harrison's and Brenner & Rector's.
Physiology of Renal Calculi (Nephrolithiasis)
Overview
Kidney stones form when solutes in the urine crystallize and aggregate in the renal collecting system. The process involves an interplay between lithogenic factors (promoters) and protective factors (inhibitors), and is best understood through several physiological mechanisms.
1. Stone Composition and Frequency
| Stone Type | Frequency |
|---|
| Calcium oxalate | ~75% |
| Calcium phosphate | ~15% |
| Uric acid | ~8% |
| Struvite (infection) | ~1% |
| Cystine | <1% |
Many stones are mixed (e.g., calcium oxalate + calcium phosphate) and also contain protein matrix. - Harrison's Principles of Internal Medicine 22E
2. Core Physiological Mechanism: Supersaturation
The fundamental driver of stone formation is urinary supersaturation - when the concentration of a solute exceeds its solubility limit in urine.
- Supersaturation creates a thermodynamic driving force for crystal nucleation and growth.
- The calculated supersaturation value does not perfectly predict stone formation because crystallization inhibitors in normal urine prevent stone formation in most people.
- Supersaturation depends on urinary concentrations of the relevant ions, urine pH, ionic strength, and the concentrations of complexing agents.
The most important protective factors are crystallization inhibitors, the most significant being urinary citrate for calcium-containing stones. - Harrison's, p. 2492
3. Randall's Plaque - The Initiation Site
A paradigm shift in understanding stone formation came from renal biopsy studies:
- Calcium phosphate deposits in the renal interstitium (at the thin limb of the loop of Henle) extend down to the papilla and erode through the papillary epithelium.
- This exposed calcium phosphate deposit at the tip of the renal papilla is called Randall's plaque, and it serves as a nidus for calcium oxalate and calcium phosphate crystal deposition.
- Most calcium oxalate stones grow on Randall's plaque.
- Tubular plugs of calcium phosphate may initiate calcium phosphate stone development separately.
- Stone formation may therefore begin years before a clinically detectable stone is identified. - Harrison's, p. 2492
4. Types of Stones - Specific Physiology
A. Calcium Oxalate Stones (most common)
Three physiological abnormalities drive calcium oxalate stone formation:
i. Hypercalciuria - excess calcium in urine, classified as:
- Absorptive hypercalciuria: Increased intestinal calcium absorption (often linked to excess 1,25-dihydroxyvitamin D or altered calcium-sensing receptor [CaSR] function). The CaSR in the kidney responds to elevated ionized calcium and reduces tubular calcium reabsorption in the thick ascending limb (TAL) and distal convoluted tubule (DCT).
- Resorptive hypercalciuria: Enhanced calcium mobilization from bone - most commonly from primary hyperparathyroidism (stones in 2-8% of PHPT patients). PTH increases skeletal calcium release and renal 1,25(OH)2D synthesis, amplifying intestinal absorption.
- Renal leak hypercalciuria: Defective tubular reabsorption of calcium, leading to secondary hyperparathyroidism and bone resorption. Tight junction proteins of the claudin family (claudin-16, claudin-19) regulate paracellular Ca²⁺ reabsorption in the TAL; mutations or dysregulation impair this. - Brenner & Rector's Kidney
ii. Hyperoxaluria - excess urinary oxalate:
- Urinary oxalate derives from both endogenous production (liver) and dietary absorption.
- Oxalate is a stronger lithogenic risk factor than urinary calcium, gram for gram.
- Low dietary calcium paradoxically increases oxalate absorption (less calcium in the gut to bind oxalate), explaining why low-calcium diets increase stone risk.
- High-dose Vitamin C supplements increase urinary oxalate (ascorbate is metabolized to oxalate).
iii. Hypocitraturia - low urinary citrate:
- Citrate is the most important inhibitor of calcium stone formation.
- It complexes with calcium in urine, reducing free ionic calcium available for crystallization.
- It also directly inhibits calcium oxalate and calcium phosphate crystal growth and aggregation.
- Low citrate is caused by: metabolic acidosis, hypokalemia, chronic diarrhea, renal tubular acidosis (distal RTA), high animal protein intake.
Hyperuricosuric calcium oxalate stones: Excess monosodium urate in urine adsorbs macromolecular inhibitors of calcium oxalate crystallization, reducing their effectiveness and promoting stone formation even when calcium oxalate supersaturation is not dramatically elevated. - Brenner & Rector's, p. 1707
B. Calcium Phosphate Stones
- Form when urine is persistently alkaline (high pH) combined with hypercalciuria.
- Classic setting: distal renal tubular acidosis (dRTA) - the distal tubule fails to acidify urine, leading to persistently alkaline urine, hypocitraturia, and hypercalciuria simultaneously.
- Also associated with primary hyperparathyroidism.
C. Uric Acid Stones (~8%)
Key physiology:
- Uric acid is the end product of purine metabolism (xanthine oxidase pathway).
- The pKa of uric acid is 5.5 - at pH below 5.5, uric acid is mostly undissociated and insoluble.
- Low urine pH (persistently acidic urine) is the single most important risk factor, more so than hyperuricosuria.
- Causes: insulin resistance/metabolic syndrome (defective ammoniagenesis leads to acid urine), gout, high purine intake, high animal protein.
- Uric acid stones are radiolucent on plain X-ray (unlike calcium stones).
D. Struvite Stones (Magnesium Ammonium Phosphate)
- Form in the presence of urease-producing bacteria (Proteus, Klebsiella, Pseudomonas).
- Urease splits urea into NH₃ + CO₂, raising urinary pH and increasing ammonium and carbonate concentrations.
- Alkaline urine + high ammonia supersaturates struvite.
- These are "infection stones" and can grow rapidly into staghorn calculi filling the renal pelvis.
E. Cystine Stones
- Result from an autosomal recessive defect in the SLC3A1 or SLC7A9 gene - the dibasic amino acid transporter in the proximal tubule.
- Impaired reabsorption of cystine, ornithine, lysine, arginine (COLA) in the proximal tubule.
- Cystine has very low solubility, particularly at acidic pH.
- Stone formation requires urinary cystine excretion typically >250 mg/g creatinine.
5. Key Protective Factors Against Stone Formation
| Inhibitor | Mechanism |
|---|
| Citrate | Chelates free calcium; inhibits crystal growth and aggregation |
| Magnesium | Forms soluble complexes with oxalate |
| Pyrophosphate | Inhibits calcium phosphate crystallization |
| Nephrocalcin | Glycoprotein that inhibits calcium oxalate nucleation |
| Tamm-Horsfall protein (uromodulin) | Inhibits calcium oxalate crystal aggregation |
| High urine volume | Dilutes all solutes, reduces supersaturation |
6. Dietary Physiological Relationships (Summary)
| Factor | Effect on Stone Risk | Mechanism |
|---|
| High fluid intake | Decreases | Lowers supersaturation |
| Low dietary calcium | Increases (counterintuitive) | More gut oxalate absorbed |
| High animal protein | Increases | ↑ uric acid, ↑ Ca excretion, ↓ citrate |
| High sodium | Increases | Impairs tubular Ca reabsorption |
| High oxalate foods | Increases | ↑ urinary oxalate |
| Potassium/alkali-rich foods | Decreases | ↑ citrate, ↓ Ca excretion |
| Vitamin C supplements | Increases (in men) | Oxalate is a Vit C metabolite |
- Harrison's Principles of Internal Medicine 22E, Chapter 330
Quick-Reference Summary
Supersaturation → Nucleation → Crystal growth → Aggregation → Stone
↑ ↓
Randall's plaque Inhibitors prevent this
(CaPO₄ in papilla) (citrate, TH protein, Mg)
The physiology of each stone type ultimately reduces to a common theme: an imbalance between lithogenic solutes (calcium, oxalate, urate, phosphate, cystine) and crystallization inhibitors (especially citrate), set against a backdrop of urine volume and pH that either promotes or prevents supersaturation.